Search

Displaying results 9601 - 9610 of 10000 in total
  1. Drug

    SKL35501

    go.drugbank.com/drugs/DB33950
    Experimental

    SKL35501 is a small molecule drug. SKL35501 is under investigation in clinical trial NCT07812805 (SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors).

  2. Drug

    HHK101

    go.drugbank.com/drugs/DB33948
    Experimental

    HHK101 is a small molecule drug. HHK101 is under investigation in clinical trial NCT07815210 (Phase I Trial of HHK101 in Patients With Schizophrenia).

  3. Drug

    Pigment epithelium-derived factor 34

    go.drugbank.com/drugs/DB33941
    Experimental

    Pigment epithelium-derived factor 34 is a biologic drug.

  4. Drug

    JZP269

    go.drugbank.com/drugs/DB33939
    Experimental

    JZP269 is a small molecule drug. … JZP269 is under investigation in clinical trial NCT07813663 (A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants).

  5. Drug

    Noscapine

    go.drugbank.com/drugs/DB06174
    Approved

  6. Drug

    Taribavirin

    go.drugbank.com/drugs/DB06408
    Investigational

  7. Drug

    Squalamine

    go.drugbank.com/drugs/DB06461
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Pafuramidine

    go.drugbank.com/drugs/DB06532
    Investigational

    Pafuramidine, a prodrug of furamidine, currently has orphan status for _Pneumocystis jiroveci_ pneumonia.

  9. Drug

    Besifloxacin

    go.drugbank.com/drugs/DB06771
    Approved

    Besifloxacin is a fourth generation fluoroquinolone-type opthalmic antibiotic for the treatment of bacterial conjunctivitis. FDA approved on May 28, 2009.

  10. Drug

    Gabapentin enacarbil

    go.drugbank.com/drugs/DB08872
    Approved

    It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).